ANGIOGENEX, INC. Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2019-06-30..
Operating margin
Overview →Financial period ending 2019-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2019-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -895.01K USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | |
| Research and development | 188.98K USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2019-06-30 | $-895.01K | (m) | (m) | $188.98K | (m) | (m) |
| 2019-03-31 | $-836.53K | (m) | (m) | $135.59K | (m) | (m) |
| 2018-12-31 | $-437.66K | (m) | (m) | $30.74K | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $-418.10K | (m) | (m) | $68.68K | (m) | (m) |
| 2018-03-31 | $-737.23K | (m) | (m) | $250.92K | (m) | (m) |
| 2017-12-31 | $-646.19K | (m) | (m) | $291.34K | (m) | (m) |
| 2017-09-30 | $-604.16K | (m) | (m) | $234.36K | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $-437.96K | (m) | (m) | $49.43K | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.